Titanium-niobium pentoxide composites for biomedical applications.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29744401.
- Also identified by DOI 10.1016/j.bioactmat.2016.10.001 and PMC identifier 5883992.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The strength of titanium scaffolds with the introduction of high porosity decreases dramatically and may become inadequate for load bearing in biomedical applications. To simultaneously meet the requirements of biocompatibility, low elastic modulus and appropriate strength for orthopedic implant materials, it is highly desirable to develop new biocompatible titanium based materials with enhanced strength. In this study, we developed a niobium pentoxide (Nb<sub>2</sub>O<sub>5</sub>) reinforced titanium composite via powder metallurgy for biomedical applications. The strength of the Nb<sub>2</sub>O<sub>5</sub> reinforced titanium composites (Ti-Nb<sub>2</sub>O<sub>5</sub>) is significantly higher than that of pure titanium. Cell culture results revealed that the Ti-Nb<sub>2</sub>O<sub>5</sub> composite exhibits excellent biocompatibility and cell adhesion. Human osteoblast-like cells grew and spread healthily on the surface of the Ti-Nb<sub>2</sub>O<sub>5</sub> composite. Our study demonstrated that Nb<sub>2</sub>O<sub>5</sub> reinforced titanium composite is a promising implant material by virtue of its high mechanical strength and excellent biocompatibility.